{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d49104e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, re\n",
    "import numpy as np\n",
    "import pickle as pkl"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d06eae30",
   "metadata": {},
   "outputs": [],
   "source": [
    "input_folder = \"../data/preprocessed_tika/\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b07ee5ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "file_to_text = {}\n",
    "for root, folder, files in os.walk(input_folder):\n",
    "    for file_name in files:\n",
    "        if not file_name.endswith(\"pkl\"):\n",
    "            continue\n",
    "        pdf_file = re.sub(\".pkl\", \"\", file_name)\n",
    "        \n",
    "        full_file = input_folder + \"/\" + file_name\n",
    "#         print (full_file)\n",
    "        with open(full_file, 'rb') as f:\n",
    "            text = pkl.load(f)\n",
    "        file_to_text[pdf_file] = text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "faf47569",
   "metadata": {},
   "outputs": [],
   "source": [
    "sap_regex = re.compile(r\"(?i)statistical\\s*analysis\\s*plan\")\n",
    "\n",
    "sap_regex = re.compile(r\"(?i)\\bSAP\\b\")\n",
    "\n",
    "sap_regex = re.compile(r\"(?i)\\bdata\\s*analysis\\s*plan\\b\")\n",
    "\n",
    "sap_regex = re.compile(r\"(?i)\\bDAP\\b\")\n",
    "\n",
    "\n",
    "sap_regex = re.compile(r\"(?i)\\b([SD]AP|(?:data|statistical)\\s*analysis\\s*plan)\\b\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "2a42af5b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n\\t\\nStatistical\\tanalysis\\tplan,\\tdated\\t14\\tDecember\\t2016 \\n\\n'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "file_to_text[\"TB-TB-2018-M-P-A.pdf\"][146]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "58c69b5e",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "TB-TB-2018-DAR-PIA.pdf 68\n",
      "\t 54 \t is of this study. A detailed  Statistical Analysis Plan (SAP) incorporating these sec\n",
      "\t 54 \t d  Statistical Analysis Plan (SAP) incorporating these sections\n",
      "\t 54 \t  approved by the Sponsor. The SAP will define populations for a\n",
      "\t 55 \t led data will be given in the Statistical Analysis Plan.    14.7 Changes in the Plann\n",
      "\t 55 \t s  If changes are made to the Statistical Analysis Plan, then these will be listed in\n",
      "TB-TB-2018-M-P-A.pdf 161\n",
      "\t 1 \t 15\t 4.\tSummary\tof\tchanges\t 5.\tStatistical\tanalysis\tplan,\tdated\t14\tDecember\t2016\t**\t \t\n",
      "\t 1 \t es\twere\tmade\tto\tthis\toriginal\tstatistical\tanalysis\tplan.\t        \n",
      "\t 49 \t l be performed according to a Statistical  Analysis Plan which will be approved before\n",
      "\t 119 \t l be performed according to a Statistical   Analysis Plan which will be approved before\n",
      "\t 146 \t  \t Statistical\tanalysis\tplan,\tdated\t14\tDecember\t2016   \n",
      "\t 160 \t  1_Graeme \ttabbladen \tPredART SAP final signed \n",
      "HIV-HIV-2016-Ayles-A Study of the HIV prevention Trials Network.pdf 166\n",
      "\t 27 \t ill  be incorporated into the statistical analysis plan as discussed in Section 7.   \n",
      "\t 32 \t and will be described in the  Statistical Analysis Plan.    If funded, the Population\n",
      "\t 77 \t ent arms will be given in the Statistical Analysis Plan  along with methods used to a\n",
      "\t 77 \t analyses will be given in the Statistical Analysis Plan.   \n",
      "TB-TB-2019-T-A-b.pdf 389\n",
      "\t 1 \t (page 202)  3. TB-018 – Final statistical analysis plan (page 304) with summary of ch\n",
      "\t 1 \t ge 349)  4. TB-018 – Original statistical analysis plan for the final analysis (page \n",
      "\t 140 \t tility will be defined in the statistical analysis plan for interim  analysis. If the\n",
      "\t 165 \t tility will be defined in the statistical analysis plan for interim  analysis.  Speci\n",
      "\t 199 \t tility will be defined in the statistical analysis plan for interim  analysis.  12.1.\n",
      "\t 304 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 304 \t al  17-OCT-2017 Page 1 of 45  Statistical Analysis Plan Approval  Protocol Title: Eff\n",
      "\t 305 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 306 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 307 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 308 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 309 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 310 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 310 \t d  SAE Serious Adverse Event  SAP Statistical Analysis Plan  SO\n",
      "\t 310 \t AE Serious Adverse Event  SAP Statistical Analysis Plan  SOC System Organ Class  SS S\n",
      "\t 311 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 311 \t  in the  Study Analysis Plan (SAP) and a Table and Figures List\n",
      "\t 312 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 313 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 314 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 315 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 316 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 317 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 318 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 319 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 320 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 321 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 322 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 323 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 324 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 325 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 326 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 327 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 328 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 329 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 330 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 331 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 332 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 333 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 334 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 335 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 336 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 337 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 338 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 339 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 340 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 341 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 342 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 343 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 344 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 345 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 346 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 347 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 348 \t AL 115616 (TUBERCULOSIS-018)  Statistical Analysis Plan Amendment 1 Final  17-OCT-201\n",
      "\t 349 \t TB-018 – Changes in the final statistical analysis plan      The analysis being trigg\n",
      "\t 349 \t th 24 visit (as in the   last statistical analysis plan) instead of the time when 21 \n",
      "\t 349 \t ccumulated (as in the first   statistical analysis plan):   - The monitoring of cases\n",
      "\t 349 \t ot as necessary for the final statistical analysis plan as for the  first statistical\n",
      "\t 349 \t alysis plan as for the  first statistical analysis plan     - The time to event was d\n",
      "\t 350 \t  CONFIDENTIAL   1            Statistical Analysis Plan Approval  Protocol Title: Eff\n",
      "\t 354 \t   SAE Serious Adverse Event   SAP Statistical Analysis Plan   T\n",
      "\t 354 \t E Serious Adverse Event   SAP Statistical Analysis Plan   TB Tuberculosis   TFL  Tabl\n",
      "\t 356 \t  in the Study  Analysis Plan (SAP) and a Table and Figures List\n",
      "\t 387 \t ation_V2 \tTB-018_Protocol and SAP compilation \tIntro page for c\n",
      "\t 387 \t pilation \tTB-018_Protocol and SAP compilation \tTB-018_Protocol \n",
      "\t 387 \t pilation \tTB-018_Protocol and SAP compilation \tgsk-115616-proto\n",
      "\t 387 \t OD \tTUBERCULOSIS-018 (115616) SAP (31-May-2016) \tLIST OF ABBREV\n",
      "\t 387 \t S  \tTUBERCULOSIS-018 (115616) SAP  amendment 5 (17-Mar-2015) \t1\n",
      "HIV-HIV-2016-Laufer-Trimethoprim-Sulfamethoxazole-Chloroquine.pdf 100\n",
      "\t 66 \t  Analysis Plan   An extensive statistical analysis plan will be developed by the Stat\n",
      "\t 66 \t g   Center for the study. The statistical analysis plan will be reviewed and finalize\n",
      "NTD-Filariasis-2019-Weil-DOLF IDA Papua New Guinea.pdf 90\n",
      "HIV-HIV-2017-Abrams-IMPAACT P1101.pdf 85\n",
      "NUT-A-2019-M-T.pdf 196\n",
      "\t 1 \t mmary of changes. 2. Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t tistical analysis plan, final statistical analysis plan, summary of changes.  \n",
      "\t 9 \t ious\t\r",
      "  adverse\t\r",
      "  events\t\r",
      "   SAP\t\r",
      "   Statistical\t\r",
      "  Analysis\t\r\n",
      "\t 9 \t adverse\t\r",
      "  events\t\r",
      "   SAP\t\r",
      "   Statistical\t\r",
      "  Analysis\t\r",
      "  Plan\t\r",
      "   SOC\t\r",
      "   Standard\t\r",
      "  of\t\r",
      " \n",
      "\t 46 \t  detail\t\r",
      "  in\t\r",
      "  a\t\r",
      "  full\t\r",
      "  Statistical\t\r",
      "  Analysis\t\r",
      "  Plan.\t\r",
      "  This\t\r",
      "  section\t\r",
      "  summar\n",
      "\t 89 \t  SAE Serious adverse events   SAP Statistical Analysis Plan   S\n",
      "\t 89 \t  Serious adverse events   SAP Statistical Analysis Plan   SOC Standard of care  SOP S\n",
      "\t 127 \t described in detail in a full Statistical Analysis Plan. This section summarises the \n",
      "\t 178 \t  1  TRACT Statistical Analysis Plan v2.0                \n",
      "\t 179 \t  2  TRACT Statistical Analysis Plan v2.0   Contents  1 Trial desi\n",
      "\t 180 \t  3  TRACT Statistical Analysis Plan v2.0   1 Trial design   1.1 D\n",
      "\t 181 \t  4  TRACT Statistical Analysis Plan v2.0   1.2 Population   Eligi\n",
      "\t 182 \t  5  TRACT Statistical Analysis Plan v2.0    cumulative mortality\n",
      "\t 182 \t  and cost-effectiveness (this SAP will not cover this analysis)\n",
      "\t 183 \t  6  TRACT Statistical Analysis Plan v2.0   scores. For children a\n",
      "\t 184 \t  7  TRACT Statistical Analysis Plan v2.0   4 Statistical analysis\n",
      "\t 185 \t  8  TRACT Statistical Analysis Plan v2.0    Haemoglobinuria: n(%\n",
      "\t 186 \t  9  TRACT Statistical Analysis Plan v2.0   Ward tests at admissio\n",
      "\t 187 \t  10  TRACT Statistical Analysis Plan v2.0    Visits considered co\n",
      "\t 188 \t  11  TRACT Statistical Analysis Plan v2.0    MVMM supplementation\n",
      "\t 189 \t  12  TRACT Statistical Analysis Plan v2.0   Kaplan-Meier curves wi\n",
      "\t 190 \t  13  TRACT Statistical Analysis Plan v2.0   The change in Hb from \n",
      "\t 191 \t  14  TRACT Statistical Analysis Plan v2.0    Serious adverse even\n",
      "\t 192 \t  15  TRACT Statistical Analysis Plan v2.0   Further pre-specified \n",
      "\t 193 \t  TRACT SAP Revision History – further de\n",
      "\t 194 \t \tTRACT_SAP_v1.0_signed \tTRACT SAP v2.0_signed \tTRACT SAP Revisi\n",
      "\t 194 \t \tTRACT SAP v2.0_signed \tTRACT SAP Revision history further deta\n",
      "HIV-HIV-2018-IMPAACT-P1112.pdf 155\n",
      "EDD-rotavirus-2017-Isanaka-ROSE.pdf 210\n",
      "\t 1 \t changes (p.138)   2. Original statistical analysis plan (p.141), final statistical an\n",
      "\t 1 \t  analysis plan (p.141), final statistical analysis plan, summary of changes (p.209)  \n",
      "\t 141 \t      Page 141 of  209         Statistical Analysis Plan (SAP)   Protocol Title:   Ran\n",
      "\t 141 \t    Statistical Analysis Plan (SAP)   Protocol Title:   Randomiz\n",
      "\t 142 \t            Page 142 of  209   Statistical Analysis Plan (SAP)   Signature Page   Type\n",
      "\t 142 \t    Statistical Analysis Plan (SAP)   Signature Page   Type of d\n",
      "\t 142 \t ature Page   Type of document Statistical Analysis Plan Identifier ROSE   Effective d\n",
      "\t 144 \t s   1. INTRODUCTION 148   1.1 STATISTICAL ANALYSIS PLAN 148   1.2 RATIONALE 148   2. \n",
      "\t 148 \t   209   1. Introduction   1.1 Statistical Analysis Plan   A statistical analysis plan\n",
      "\t 148 \t Statistical Analysis Plan   A statistical analysis plan is a comprehensive and detail\n",
      "\t 148 \t nical trial. A clear detailed SAP will avoid post hoc decisions\n",
      "\t 148 \t erpretation of the data. This SAP includes details on the proce\n",
      "\t 148 \t s in healthy infants.    This statistical analysis plan will provide full details of \n",
      "\t 148 \t be explained in this detailed statistical analysis plan of the   study. The SAP was d\n",
      "\t 148 \t ysis plan of the   study. The SAP was developed before any data\n",
      "\t 148 \t ed to the study team.    This SAP:     Includes a statement of\n",
      "\t 148 \t les, etc.    By the time this SAP was competed and approval by \n",
      "\t 209 \t e have been no changes to the SAP           \n",
      "NTD-Y-2019-M-Y.pdf 66\n",
      "\t 1 \t tocol, including the original statistical analysis plan   2. Final protocol, includin\n",
      "\t 1 \t protocol, including the final statistical analysis plan   3. Summary of changes.   \n",
      "\t 4 \t  MAJOR ASSUMPTIONS     17   7 STATISTICAL ANALYSIS PLAN 18   7.1 Data management 19  \n",
      "\t 19 \t tocol: 07.03.2013   18     7. Statistical analysis plan   7.1 Data management   Only \n",
      "\t 35 \t  MAJOR ASSUMPTIONS     18   7 STATISTICAL ANALYSIS PLAN 19   7.1 Data management 19  \n",
      "\t 51 \t tocol: 02.11.2013   19     7. Statistical analysis plan   7.1 Data management   Only \n",
      "\t 65 \t mplemented with regard to the statistical analysis plan within   the protocol.    \n",
      "NTD-Chagas-2015-Morillo-BENEFIT.pdf 76\n",
      "\t 1 \t nges   4. BENEFIT Trial Final Statistical Analysis Plan (version 1.0)       \n",
      "\t 59 \t  1            STATISTICAL ANALYSIS PLAN     THE BENEFIT Trial  BENzni\n",
      "\t 62 \t SAE  Serious Adverse Event    SAP Statistical Analysis Plan   S\n",
      "\t 62 \t  Serious Adverse Event    SAP Statistical Analysis Plan   SD Standard Deviation   VT \n",
      "\t 62 \t     2. INTRODUCTION      This statistical analysis plan (SAP) provides a comprehensiv\n",
      "\t 62 \t is statistical analysis plan (SAP) provides a comprehensive and\n",
      "\t 62 \t  2, 2009). The objective of a Statistical Analysis Plan is to ensure the maximum   cr\n",
      "\t 62 \t comes by treatment group. The SAP is a working   document that \n",
      "\t 62 \t es.  The final version of the SAP will be signed   off prior to\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 74 \t Committee   \tchanges \tBENEFIT SAP Final V 1 0 2015-06-13 \n",
      "MAT-V-2018-R-M.pdf 193\n",
      "\t 1 \t mmary of changes  2. Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t ed in March 2014.    b ‘Final statistical analysis plan’ includes definitions and ana\n",
      "\t 52 \t #1, #2 and #3)    *A detailed data analysis plan is in development, and will b\n",
      "\t 123 \t #1, #2 and #3)    *A detailed data analysis plan is in development, and will b\n",
      "\t 150 \t              Statistical Analysis Plan      Randomized placebo-contr\n",
      "\t 151 \t  MDIG Statistical Analysis Plan  2   Version 1  December 15, \n",
      "\t 152 \t  MDIG Statistical Analysis Plan  3   Version 1  December 15, \n",
      "\t 153 \t  MDIG Statistical Analysis Plan  4   Version 1  December 15, \n",
      "\t 154 \t  MDIG Statistical Analysis Plan  5   Version 1  December 15, \n",
      "\t 155 \t  MDIG Statistical Analysis Plan 6   Version 1 December 15, 20\n",
      "\t 156 \t  MDIG Statistical Analysis Plan  7   Version 1  December 15, \n",
      "\t 156 \t d in the protocol and in this Statistical Analysis Plan will be   performed only afte\n",
      "\t 157 \t  MDIG Statistical Analysis Plan  8   Version 1  December 15, \n",
      "\t 158 \t  MDIG Statistical Analysis Plan  9   Version 1  December 15, \n",
      "\t 159 \t  MDIG Statistical Analysis Plan  10   Version 1  December 15,\n",
      "\t 160 \t  MDIG Statistical Analysis Plan  11   Version 1  December 15,\n",
      "\t 161 \t  MDIG Statistical Analysis Plan  12   Version 1  December 15,\n",
      "\t 162 \t  MDIG Statistical Analysis Plan  13   Version 1  December 15,\n",
      "\t 163 \t  MDIG Statistical Analysis Plan  14   Version 1  December 15,\n",
      "\t 164 \t              Statistical Analysis Plan      Randomized placebo-contr\n",
      "\t 165 \t  MDIG Statistical Analysis Plan  2   Version 1.5     May 2017\n",
      "\t 166 \t  MDIG Statistical Analysis Plan  3   Version 1.5     May 2017\n",
      "\t 167 \t  MDIG Statistical Analysis Plan  4   Version 1.5     May 2017\n",
      "\t 168 \t  MDIG Statistical Analysis Plan  5   Version 1.5     May 2017\n",
      "\t 169 \t  MDIG Statistical Analysis Plan  6   Version 1.5     May 2017\n",
      "\t 170 \t  MDIG Statistical Analysis Plan  7   Version 1.5     May 2017\n",
      "\t 171 \t  MDIG Statistical Analysis Plan  8   Version 1.5     May 2017\n",
      "\t 171 \t d in the protocol and in this Statistical Analysis Plan will be   performed only afte\n",
      "\t 172 \t  MDIG Statistical Analysis Plan  9   Version 1.5     May 2017\n",
      "\t 173 \t  MDIG Statistical Analysis Plan  10   Version 1.5     May 201\n",
      "\t 174 \t  MDIG Statistical Analysis Plan  11   Version 1.5     May 201\n",
      "\t 175 \t  MDIG Statistical Analysis Plan  12   Version 1.5     May 201\n",
      "\t 176 \t  MDIG Statistical Analysis Plan  13   Version 1.5     May 201\n",
      "\t 177 \t  MDIG Statistical Analysis Plan  14   Version 1.5     May 201\n",
      "\t 178 \t  MDIG Statistical Analysis Plan  15   Version 1.5     May 201\n",
      "\t 179 \t  MDIG Statistical Analysis Plan  16   Version 1.5     May 201\n",
      "\t 180 \t  MDIG Statistical Analysis Plan  17   Version 1.5     May 201\n",
      "\t 181 \t  MDIG Statistical Analysis Plan  18   Version 1.5     May 201\n",
      "\t 182 \t  MDIG Statistical Analysis Plan  19   Version 1.5     May 201\n",
      "\t 183 \t  MDIG Statistical Analysis Plan  20   Version 1.5     May 201\n",
      "\t 184 \t  MDIG Statistical Analysis Plan  21   Version 1.5     May 201\n",
      "\t 185 \t  MDIG Statistical Analysis Plan  22   Version 1.5     May 201\n",
      "\t 186 \t  MDIG Statistical Analysis Plan 23   Version 1.5  May 2017   \n",
      "\t 187 \t  MDIG Statistical Analysis Plan 24   Version 1.5  May 2017   \n",
      "\t 188 \t  Amendments to the statistical analysis plan from the original to final pl\n",
      "HIV-HIV-2018-GSK1265744.pdf 124\n",
      "POL-P-2018-O-A-L.pdf 97\n",
      "\t 4 \t Deviation from the Original   Statistical Analysis Plan .............................\n",
      "\t 8 \t   SAE serious adverse event   SAP statistical analysis plan   S\n",
      "\t 8 \t E serious adverse event   SAP statistical analysis plan   SOP standard operating proc\n",
      "\t 37 \t  Deviation from the Original  Statistical Analysis Plan   The Statistical Analysis Pl\n",
      "\t 37 \t atistical Analysis Plan   The Statistical Analysis Plan (SAP) may be amended at any t\n",
      "\t 37 \t he Statistical Analysis Plan (SAP) may be amended at any time d\n",
      "\t 37 \t  data.  All versions   of the SAP up to and including the final\n",
      "\t 37 \t o and including the finalized SAP will be archived in the study\n",
      "\t 37 \t es described in the finalized SAP will be performed as specifie\n",
      "\t 37 \t  that are not included in the SAP may be specified subsequent t\n",
      "\t 37 \t  an addendum to the finalized SAP and will be performed if   ag\n",
      "MAT-Hypothermia-2018-Hansen-Electricity-free Infant Warmer.pdf 56\n",
      "EDD-T-2019-S-T.pdf 105\n",
      "\t 1 \t mary of changes.  2. Original statistical analysis plan (no changes)   \n",
      "\t 31 \t  female      A fully detailed statistical analysis plan will be prepared and signed o\n",
      "\t 32 \t Statistical Plan   A detailed statistical analysis plan will be prepared and signed o\n",
      "\t 74 \t  female      A fully detailed statistical analysis plan will be prepared and signed o\n",
      "\t 76 \t Statistical Plan   A detailed statistical analysis plan will be prepared and signed o\n",
      "\t 91 \t  TYGER (OVG 2016/03) – Statistical Analysis Plan - Version 0.5, 24 AUG 2017   \n",
      "\t 91 \t  - Version 0.5, 24 AUG 2017   STATISTICAL ANALYSIS PLAN       TYVAC NEPAL     Short t\n",
      "\t 92 \t  TYGER (OVG 2016/03) – Statistical Analysis Plan - Version 1.0, 18 SEPT 2017  \n",
      "\t 93 \t  TYGER (OVG 2016/03) – Statistical Analysis Plan - Version 0.5, 24 AUG 2017   \n",
      "\t 94 \t  Statistical Analysis Plan    Page 4 of 13  CONFIDENTIAL\n",
      "\t 95 \t  Statistical Analysis Plan    Page 5 of 13  CONFIDENTIAL\n",
      "\t 96 \t  Statistical Analysis Plan    Page 6 of 13  CONFIDENTIAL\n",
      "\t 97 \t  Statistical Analysis Plan    Page 7 of 13  CONFIDENTIAL\n",
      "\t 98 \t  Statistical Analysis Plan    Page 8 of 13  CONFIDENTIAL\n",
      "\t 99 \t  Statistical Analysis Plan    Page 9 of 13  CONFIDENTIAL\n",
      "\t 100 \t  Statistical Analysis Plan    Page 10 of 13  CONFIDENTIA\n",
      "\t 101 \t  Statistical Analysis Plan    Page 11 of 13  CONFIDENTIA\n",
      "\t 102 \t  Statistical Analysis Plan    Page 12 of 13  CONFIDENTIA\n",
      "\t 103 \t  Statistical Analysis Plan    Page 13 of 13  CONFIDENTIA\n",
      "NTD-Hookwork-2018-Keiser-Efficacy and safety of a single.pdf 51\n",
      "TB-TB-2018-Piazza-A Phase 1b, Randomized, Double-blind.pdf 56\n",
      "\t 7 \t ology, to be described in the statistical analysis plan, and will  be summarized as n\n",
      "\t 35 \t e outlined below.  A detailed statistical analysis  plan will be created and finalized\n",
      "\t 35 \t iations (to be defined in the statistical analysis plan) will be provided.     7.3 Ef\n",
      "\t 36 \t  (12), to be described in the statistical analysis plan, and will be summarized as  n\n",
      "\t 38 \t ysis will be provided  in the statistical analysis plan.     7.7.3 Final Study Report\n",
      "\t 38 \t  be included in the relevant  statistical analysis plan(s).  Any decisions to deviate\n",
      "\t 38 \t d in the  protocol and in the statistical analysis plan will be described in detail i\n",
      "MAL-Malaria-2019-Llanos-Cuentas-Tafenoquine vs. Primaquine to.pdf 402\n",
      "\t 199 \t anges to the Protocol Defined Statistical Analysis Plan ............................7\n",
      "\t 204 \t anges to the Protocol Defined Statistical Analysis Plan  There are changes or deviati\n",
      "\t 291 \t anges to the Protocol Defined Statistical Analysis Plan ............................6\n",
      "\t 295 \t anges to the Protocol Defined Statistical Analysis Plan  There are changes or deviati\n",
      "\t 401 \t anges to the Protocol Defined Statistical Analysis Plan \t2.2. Study Objective(s) and \n",
      "\t 401 \t anges to the Protocol Defined Statistical Analysis Plan \t2.2. Study Objective(s) and \n",
      "HIV-HIV-2017-Corey-HVTN703-HPTN081.pdf 193\n",
      "\t 61 \t pecific   infusion visit, the Statistical Analysis Plan will address how to analyze t\n",
      "\t 63 \t treatment arms [124,125]. The Statistical Analysis Plan will describe the details of \n",
      "\t 66 \t    A correlates of protection statistical analysis plan will be finalized not using a\n",
      "\t 66 \t V-1 virus at that time.   The statistical analysis plan will describe the methods use\n",
      "\t 67 \t thods will be provided in the statistical analysis plan.   4.11.7.4 mAb markers    Fo\n",
      "\t 69 \t ons will be   provided in the statistical analysis plan.    Figure 4-8 shows power cu\n",
      "MAL-M-2019-A-S.pdf 92\n",
      "\t 57 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 57 \t 17)-signed     Page 1 of 34   STATISTICAL ANALYSIS PLAN  Trial title: Intermittent Sc\n",
      "\t 57 \t  Lukito (site Data Manager)   SAP authors: Rukhsana Ahmed, Caro\n",
      "\t 57 \t  Tropical Medicine (LSTM)     SAP version History:   Version Da\n",
      "\t 57 \t rsion History:   Version Date SAP  version #   Details of Chang\n",
      "\t 58 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 59 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 60 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 61 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 62 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 63 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 64 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 64 \t is document is to outline the statistical analysis plan for the STOPMiP trial. The  p\n",
      "\t 64 \t d P.vivax in Indonesia.   The SAP is based on the version of th\n",
      "\t 65 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 66 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 67 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 68 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 69 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 70 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 71 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 72 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 73 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 74 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 75 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 76 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 77 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 78 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 79 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 80 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 81 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 82 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 83 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 84 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 85 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 86 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 87 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 88 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 89 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 90 \t  STOPMIP Indonesia SAP (v1.1-24Mar17)-signed     Pag\n",
      "\t 91 \t (THELANCETID-D-19-00077) with SAP (1).pdf \tSMI-web appendix 15F\n",
      "\t 91 \t -19-00077) \tSTOPMIP Indonesia SAP (v1.1-24Mar17)-signed \t1. Lis\n",
      "NTD-E-2017-A-A.pdf 60\n",
      "HIV-HIV-2017-Bekker-HVTN100.pdf 154\n",
      "MAL-Malaria-2019-Tinto-Extension to study MALARIA-055 PRI.pdf 100\n",
      "NUT-NUT-2019-A-I.pdf 132\n",
      "\t 49 \t S/he will analyze data as per data analysis plan. S/he will provide required s\n",
      "HIV-HIV-2018-M-A.pdf 182\n",
      "HIV-HIV-2017-L-I.pdf 148\n",
      "\t 1 \t ection 4 – Original and final statistical analysis plan .............................\n",
      "\t 61 \t ir Gray).    Experimental and data analysis plan:   The objective of the analy\n",
      "\t 128 \t ir Gray).    Experimental and data analysis plan:   The objective of the analy\n",
      "\t 138 \t ection 4 – Original and final statistical analysis plan    Statistical analysis plan \n",
      "\t 138 \t  statistical analysis plan    Statistical analysis plan for the 11CN study (ISRCTN975\n",
      "TB-TB-2019-M-A.pdf 115\n",
      "\t 1 \t  operating procedures and the data analysis plan   1. Protocol section of IRB \n",
      "\t 1 \t g children born 2004-2011  7. Data analysis plan      \n",
      "\t 109 \t in a high prevalence setting  Data analysis plan   Defining the study populati\n",
      "\t 113 \t . Reference \t23. Reference   \tData Analysis Plan \tCommunity-wide screening for\n",
      "\t 113 \t in a high prevalence setting \tData analysis plan \tData analysis plan \tDefining\n",
      "\t 113 \t  setting \tData analysis plan \tData analysis plan \tDefining the study populatio\n",
      "VAC-G-2016-VAC-G-2016-V.pdf 48\n",
      "HIV-HIV-2016-N-S.pdf 358\n",
      "\t 1 \t mary of changes   2. Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t tistical analysis plan, final statistical analysis plan, summary   of changes   \n",
      "\t 7 \t AE    Serious Adverse Event   SAP    Statistical Analysis Plan \n",
      "\t 7 \t erious Adverse Event   SAP    Statistical Analysis Plan   STI    Sexually Transmitted\n",
      "\t 16 \t tegy will be specified in the Statistical Analysis Plan (SAP).    AEs will be assesse\n",
      "\t 16 \t he Statistical Analysis Plan (SAP).    AEs will be assessed at \n",
      "\t 17 \t egy will be  specified in the SAP.    Exit visit - 6 weeks afte\n",
      "\t 29 \t egy will be specified  in the Statistical Analysis Plan (SAP).    AEs will be assesse\n",
      "\t 29 \t he Statistical Analysis Plan (SAP).    AEs will be assessed at \n",
      "\t 29 \t tegy will be specified in the SAP.    Exit visit (6 weeks after\n",
      "\t 66 \t ll be further defined in  the SAP.  In addition, a dichotomous \n",
      "\t 66 \t e described more fully in the SAP. The proportion of participan\n",
      "\t 67 \t ded in greater detail in the  SAP.      Acceptability of the ri\n",
      "\t 67 \t ill be fully described in the SAP.        For both types of ass\n",
      "\t 89 \t AE    Serious Adverse Event   SAP    Statistical Analysis Plan \n",
      "\t 89 \t erious Adverse Event   SAP    Statistical Analysis Plan   STI    Sexually Transmitted\n",
      "\t 98 \t tegy will be specified in the Statistical Analysis Plan  (SAP).    AEs will be assess\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 98 \t e Statistical Analysis Plan  (SAP).    AEs will be assessed at \n",
      "\t 99 \t egy will be  specified in the SAP.    Exit visit - 6 weeks afte\n",
      "\t 111 \t tegy will be specified in the SAP.    AEs will be assessed at a\n",
      "\t 111 \t tegy will be specified in the SAP.    Exit visit (6 weeks after\n",
      "\t 147 \t analyses will be written in a SAP, which will be finalised prio\n",
      "\t 149 \t ll be further defined in  the SAP.  In addition, a dichotomous \n",
      "\t 149 \t e described more fully in the SAP. The proportion of participan\n",
      "\t 149 \t ded in greater detail in the  SAP.      Acceptability of the r\n",
      "\t 149 \t ill be fully described in the SAP.      \n",
      "\t 151 \t ed by the DSMB.    A separate SAP for the interim analysis/anal\n",
      "\t 151 \t r will review and approve the SAP for any interim analysis befo\n",
      "\t 174 \t tegy will be specified in the Statistical Analysis Plan (SAP).      AEs will be asses\n",
      "\t 174 \t he Statistical Analysis Plan (SAP).      AEs will be assessed a\n",
      "\t 174 \t egy will be specified in the  SAP.      Exit visit - 6 weeks af\n",
      "\t 174 \t tegy will be specified in the Statistical Analysis Plan (SAP).      AEs will be asses\n",
      "\t 174 \t he Statistical Analysis Plan (SAP).      AEs will be assessed a\n",
      "\t 174 \t egy will be specified in the  SAP.      Exit visit - 6 weeks af\n",
      "\t 184 \t tegy will be specified in the Statistical Analysis Plan (SAP).      AEs will be asses\n",
      "\t 184 \t he Statistical Analysis Plan (SAP).      AEs will be assessed a\n",
      "\t 184 \t tegy will be specified in the Statistical Analysis Plan (SAP).      AEs will be asses\n",
      "\t 184 \t he Statistical Analysis Plan (SAP).      AEs will be assessed a\n",
      "\t 208 \t analyses will be written in a SAP, which will be finalised prio\n",
      "\t 212 \t  continued.        A separate SAP will be drafted after the pro\n",
      "\t 212 \t r will review and approve the SAP before any analyses are  unde\n",
      "\t 216 \t tegy will be specified in the Statistical Analysis Plan (SAP).      AEs will be asses\n",
      "\t 216 \t he Statistical Analysis Plan (SAP).      AEs will be assessed a\n",
      "\t 216 \t tegy will be specified in the Statistical Analysis Plan  (SAP).      AEs will be asse\n",
      "\t 216 \t e Statistical Analysis Plan  (SAP).      AEs will be assessed a\n",
      "\t 217 \t tegy will be specified in the SAP.      AEs will be assessed at\n",
      "\t 217 \t tegy will be specified in the SAP.      AEs will be assessed at\n",
      "\t 239 \t  continued.        A separate SAP will be drafted after the pro\n",
      "\t 239 \t r will review and approve the SAP before any analyses are  unde\n",
      "\t 239 \t  by the DSMB.      A separate SAP for the interim analysis/anal\n",
      "\t 239 \t r will review and approve the SAP for any interim analysis befo\n",
      "\t 244 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 244 \t ober 2013   Page 1 of 23      STATISTICAL ANALYSIS PLAN  FOR INTERIM ANALYSIS      A \n",
      "\t 246 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 246 \t AE    Serious Adverse Event   SAP    Statistical Analysis Plan \n",
      "\t 246 \t erious Adverse Event   SAP    Statistical Analysis Plan   SAS    Statistical Analysis\n",
      "\t 247 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 248 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 249 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 249 \t   This document serves as the Statistical Analysis Plan (SAP) for the interim analysi\n",
      "\t 249 \t he Statistical Analysis Plan (SAP) for the interim analysis for\n",
      "\t 249 \t ed analyses described in this SAP will be included in regulator\n",
      "\t 249 \t following is presented in the Statistical Analysis Plan for the   final analysis:   \n",
      "\t 250 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 251 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 252 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 252 \t IS AND REPORTING   A separate SAP has been prepared, detailing \n",
      "\t 252 \t  and safety analyses.    This SAP will be finalised and approve\n",
      "\t 253 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 254 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 255 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 256 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 257 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 258 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 259 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 260 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 261 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 262 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 263 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 264 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 265 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 265 \t l and will be included in the SAP   for the final efficacy and \n",
      "\t 266 \t  IPM 027  Statistical Analysis Plan for Interim Analysis, Version\n",
      "\t 267 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 267 \t ober 2013   Page 1 of 43      STATISTICAL ANALYSIS PLAN     A MULTI-CENTRE, RANDOMISE\n",
      "\t 268 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 268 \t OVAL SIGNATURE PAGE  IPM 027– Statistical Analysis Plan      A MULTI-CENTRE, RANDOMIS\n",
      "\t 268 \t ave read the above referenced Statistical Analysis Plan and approve its contents.    \n",
      "\t 269 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 269 \t AE    Serious Adverse Event   SAP    Statistical Analysis Plan \n",
      "\t 269 \t erious Adverse Event   SAP    Statistical Analysis Plan   SD    Standard Deviation   \n",
      "\t 270 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 271 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 272 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 273 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 273 \t   This document serves as the Statistical Analysis Plan (SAP) for the primary and   s\n",
      "\t 273 \t he Statistical Analysis Plan (SAP) for the primary and   second\n",
      "\t 273 \t  analyses described in this   SAP will be included in regulator\n",
      "\t 273 \t ecessarily identified in this SAP may be performed to support  \n",
      "\t 274 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 275 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 276 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 277 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 278 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 278 \t efficacy results.  A separate SAP has   been compiled for the i\n",
      "\t 278 \t nalysis, are presented in the SAP for the interim   analysis.  \n",
      "\t 279 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 279 \t d in the protocol and in this SAP will be   performed only afte\n",
      "\t 280 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 280 \t follows (also detailed in the SAP for the interim analysis):   \n",
      "\t 281 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 282 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 283 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 284 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 285 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 286 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 287 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 288 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 289 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 290 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 291 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 292 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 293 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 294 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 295 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 296 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 297 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 298 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 299 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 300 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 301 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 302 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 303 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 304 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 305 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 306 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 307 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 308 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 309 \t  IPM 027  Statistical Analysis Plan, Version 0.11   Version Dated\n",
      "\t 310 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 310 \t mber 2015   Page 1 of 47      STATISTICAL ANALYSIS PLAN     A MULTI-CENTRE, RANDOMISE\n",
      "\t 312 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 312 \t AE    Serious Adverse Event   SAP    Statistical Analysis Plan \n",
      "\t 312 \t erious Adverse Event   SAP    Statistical Analysis Plan   SD    Standard Deviation   \n",
      "\t 313 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 314 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 315 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 316 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 317 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 317 \t   This document serves as the Statistical Analysis Plan (SAP) for the protocol pre-  \n",
      "\t 317 \t he Statistical Analysis Plan (SAP) for the protocol pre-  speci\n",
      "\t 317 \t ed analyses described in this SAP will form the basis for the a\n",
      "\t 317 \t ecessarily identified in this SAP may be performed to support t\n",
      "\t 318 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 319 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 320 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 321 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 322 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 322 \t Interim Analyses   A separate SAP has been compiled for the int\n",
      "\t 322 \t nalysis, are presented in the SAP for the interim analysis.    \n",
      "\t 323 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 323 \t Analysis and Reporting   This SAP will be approved before final\n",
      "\t 323 \t d in the protocol and in this SAP will be performed only after \n",
      "\t 324 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 324 \t follows (also detailed in the SAP for the interim analysis):   \n",
      "\t 325 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 326 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 327 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 328 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 329 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 330 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 331 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 332 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 333 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 334 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 335 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 336 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 337 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 338 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 339 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 340 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 341 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 342 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 343 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 344 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 345 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 346 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 347 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 348 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 349 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 350 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 351 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 352 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 353 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 354 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 355 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 356 \t  IPM 027  Statistical Analysis Plan, Version 1.0   Version Dated:\n",
      "\t 357 \t ysis_v0.11_22OCT2013 \tIPM 027 SAP for Final Analysis_v1.0_03DEC\n",
      "\t 357 \t 1.0_03DEC2015_signed \tIPM 027 SAP for Final Analysis_v1.0_03DEC\n",
      "\t 357 \t .0_03DEC2015 \t15Dec03_IPM 027 SAP for Final analysis v1.0 signe\n",
      "\t 357 \t .0 signed MB NVN AMN \tIPM 027 SAP for Final Analysis_v1.0_03DEC\n",
      "VAC-Shigellosis-2019-Raqib-Shigella WRSS1 Vaccine trial in Bangladesh.pdf 64\n",
      "\t 51 \t al Analysis Plan   A thorough Statistical Analysis Plan will be developed before any \n",
      "HIV-HIV-2017-Evolocumab-AMG145.pdf 95\n",
      "TB-TB-2015-D-A.pdf 124\n",
      "\t 1 \t ary of changes.   2. Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t tistical analysis plan, final statistical analysis plan, summary of changes  \n",
      "\t 108 \t ur 123                        Statistical analysis plan       Original statistical an\n",
      "\t 108 \t  analysis plan       Original statistical analysis plan (French)     1er Mars 2013   \n",
      "\t 114 \t r 123                         Statistical analysis plan       Final statistical analy\n",
      "\t 114 \t cal analysis plan       Final statistical analysis plan (French)     2 Décembre 2014 \n",
      "POL-P-2016-G-T.pdf 62\n",
      "TB-TB-2019-Suliman-A Phase I_IIa Double-Blind.pdf 75\n",
      "\t 9 \t ection will be specified in a statistical analysis plan to  be finalized prior to the\n",
      "\t 16 \t ection will be specified in a statistical analysis plan to  be finalized prior to the\n",
      "\t 43 \t e outlined below.  A detailed statistical analysis  plan will be created and finalized\n",
      "\t 43 \t iations (to be defined in the statistical analysis plan) will be provided.     7.3 Ef\n",
      "\t 47 \t  Final Version 2.0            statistical analysis plan to be finalized prior to the \n",
      "\t 47 \t  be included in the relevant  statistical analysis plan(s).  Any decisions to deviate\n",
      "\t 47 \t d in the  protocol and in the statistical analysis plan will be described in detail i\n",
      "\t 52 \t ction will  be specified in a statistical analysis plan to  be finalized prior to the\n",
      "\t 52 \t ction will  be specified in a statistical analysis plan to  be finalized prior to the\n",
      "MAT-Anemia-2015-Etheredge-Prenatal Iron Supplements Safety and.pdf 46\n",
      "HIV-HIV-2016-R-E.pdf 452\n",
      "\t 1 \t  2\t\r",
      "   a. Overall\t\r",
      "  Study\t\r",
      "  Statistical\t\r",
      "  Analysis\t\r",
      "  Plan*………………………….………….page\t\r",
      "  78\t\r",
      " \n",
      "HIV-HIV-2019-H-S.pdf 242\n",
      "\t 1 \t col version 2.0.  2. Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t tistical analysis plan, final statistical analysis plan, summary of changes.         \n",
      "\t 146 \t e study protocol, the primary statistical analysis plan,  and the trial safety stoppi\n",
      "\t 198 \t ch in rural Uganda and Kenya  Statistical Analysis Plan for Phase I:  Health Outcomes\n",
      "\t 238 \t  Statistical Analysis Plan for SEARCH Study  Summary of \n",
      "\t 240 \t combined 2018-12-07 \tProtocol-SAP cover page \tSEARCH protocol v\n",
      "\t 240 \t ov2017   \tSummary of Changes- SAP v1.0 to v 3.0 \n",
      "NTD-Filariasis-2019-Weil-DOLF IDA Haiti.pdf 67\n",
      "MAT-MAT-2018-G-F.pdf 60\n",
      "\t 27 \t odel will be specified in the Statistical Analysis   Plan.   The second primary outcome\n",
      "\t 28 \t sures will be provided in the Statistical Analysis   Plan.   2.3 Study Timeline  A six-\n",
      "EDD-R-2017-G-V.pdf 125\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 81 \t ens are derived.   A detailed statistical analysis plan for preparation of the final \n",
      "\t 88 \t oint will be described in the Statistical  Analysis Plan.   All testing and inference \n",
      "MAT-HIV-2016-Fowler-PROMISE.pdf 902\n",
      "\t 1 \t ary of changes.   2. Original statistical analysis plan (contained in 1077BF Version \n",
      "\t 1 \t  1077FF Version 1.0),   final statistical analysis plan (Version 1.0, 29 July 2014), \n",
      "\t 185 \t alyses will be described in a statistical analysis plan that will be developed once  \n",
      "\t 189 \t alyses will be described in a statistical analysis plan that will be developed once  \n",
      "\t 195 \t alyses will be described in a statistical analysis plan that will be developed once  \n",
      "\t 200 \t alyses will be described in a statistical analysis plan that will be developed once  \n",
      "\t 355 \t alyses will be described in a statistical analysis plan that will be  developed once \n",
      "\t 361 \t alyses will be described in a statistical analysis plan that will be  developed once \n",
      "\t 593 \t alyses will be described in a statistical analysis plan that will be developed  once \n",
      "\t 598 \t alyses will be described in a statistical analysis plan that will be developed  once \n",
      "\t 606 \t alyses will be described in a statistical analysis plan that will be developed  once \n",
      "\t 782 \t alyses will be described in a statistical analysis plan that will be developed  once \n",
      "\t 790 \t alyses will be described in a statistical analysis plan that will be developed  once \n",
      "\t 857 \t                         Final Statistical Analysis Plan (SAP) – Version 1.0, July 29,\n",
      "\t 857 \t al Statistical Analysis Plan (SAP) – Version 1.0, July 29,  201\n",
      "\t 857 \t 14        NOTE:      Original SAP is contained in Section 7.1: \n",
      "\t 857 \t ol, Version 2.0     A revised SAP is contained in Section 6.1: \n",
      "\t 858 \t 77BA/1077FA)                  Statistical Analysis Plan   Version 1.0                \n",
      "\t 859 \t  STUDY Antepartum   Component Statistical Analysis Plan   Version 1.0, Date: July 29,\n",
      "\t 860 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.1)   7 February 20\n",
      "\t 860 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.2)   30 March 2011\n",
      "\t 860 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.3)   22 April 2011\n",
      "\t 860 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.4)   3 May 2011  I\n",
      "\t 860 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.5)   \n",
      "\t 861 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.6)   24 July 2013 \n",
      "\t 861 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.7)   10 September \n",
      "\t 861 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 0.8)   29 July 2014 \n",
      "\t 861 \t STUDY Antepartum Component    Statistical Analysis Plan (Version 1.0)       \n",
      "\t 899 \t ROMISE Antepartum Component   Statistical Analysis Plan      Original/updated version\n",
      "\t 899 \t  PROMISE Antepartum Component Statistical Analysis Plan (SAP) was contained in   Sect\n",
      "\t 899 \t nt Statistical Analysis Plan (SAP) was contained in   Section 7\n",
      "\t 899 \t  PROMISE Antepartum Component Statistical Analysis Plan (SAP) was contained in   Sect\n",
      "\t 899 \t nt Statistical Analysis Plan (SAP) was contained in   Section 6\n",
      "\t 899 \t ain changes from the original SAP to the updated SAP are:      \n",
      "\t 899 \t e original SAP to the updated SAP are:       In Version 2.0 of \n",
      "\t 899 \t -RTV arm.  Thus, the original SAP in   Section 7.16 of PROMISE \n",
      "\t 899 \t  but safety could differ, the SAP   in Section 6.16 of the PROM\n",
      "\t 899 \t ges from the original/updated SAP to the final SAP include:    \n",
      "\t 899 \t inal/updated SAP to the final SAP include:        Both the ori\n",
      "\t 899 \t icacy  endpoint. In the final SAP, each analysis is specificall\n",
      "\t 899 \t n and  objectives, making the SAP a self-contained complete doc\n",
      "TB-TB-2018-H-A.pdf 365\n",
      "\t 1 \t .......... 173   The original SAP .............................\n",
      "\t 1 \t ............. 180   The final SAP (amendment 1) ...............\n",
      "\t 1 \t ............ 270   Summary of SAP changes .....................\n",
      "\t 24 \t alues will be included in the statistical analysis plan.     The secondary analysis w\n",
      "\t 50 \t re outlined below. A detailed statistical analysis  plan will be created and finalized\n",
      "\t 50 \t tions (to be described in the statistical analysis plan).  The intent-to-treat popula\n",
      "\t 51 \t iations (to be defined in the statistical analysis  plan) will be presented by treatme\n",
      "\t 55 \t  be included in the relevant  statistical analysis plan(s).  Any decisions to deviate\n",
      "\t 55 \t d in the  protocol and in the statistical analysis plan will be described in detail i\n",
      "\t 104 \t alues will be included in the statistical analysis plan.     The secondary analysis w\n",
      "\t 133 \t re outlined below. A detailed statistical analysis  plan will be created and finalized\n",
      "\t 133 \t tions (to be described in the statistical analysis plan).  The intent-to-treat popula\n",
      "\t 133 \t iations (to be defined in the statistical analysis  plan) will be presented by treatme\n",
      "\t 138 \t  be included in the relevant  statistical analysis plan(s).  Any decisions to deviate\n",
      "\t 138 \t d in the  protocol and in the statistical analysis plan will be described in detail i\n",
      "\t 180 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 1 \n",
      "\t 180 \t COL C‐040‐404   Page 1 of 90  STATISTICAL ANALYSIS PLAN   FINAL ANALYSIS        C‐040\n",
      "\t 181 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 2 \n",
      "\t 181 \t COL C‐040‐404   Page 2 of 90  STATISTICAL ANALYSIS PLAN SIGNATURE PAGE   Statistical \n",
      "\t 181 \t NALYSIS PLAN SIGNATURE PAGE   Statistical Analysis Plan Version 1.0 (Dated 26JUL2017)\n",
      "\t 181 \t d approve this version of the Statistical Analysis Plan, authorizing  that the conten\n",
      "\t 182 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 3 \n",
      "\t 183 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 4 \n",
      "\t 184 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 5 \n",
      "\t 185 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 6 \n",
      "\t 186 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 7 \n",
      "\t 187 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 8 \n",
      "\t 188 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 9 \n",
      "\t 189 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 10\n",
      "\t 189 \t erformed on the data.    This SAP is based on protocol Final Ve\n",
      "\t 190 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 11\n",
      "\t 191 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 12\n",
      "\t 192 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 13\n",
      "\t 193 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 14\n",
      "\t 194 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 15\n",
      "\t 195 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 16\n",
      "\t 196 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 17\n",
      "\t 196 \t  be performed as part of this SAP, as agreed by Aeras:  o Ident\n",
      "\t 196 \t prepare a separate correlates SAP once the trial’s efficacy res\n",
      "\t 197 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 18\n",
      "\t 197 \t  reviews, based on a separate statistical analysis plan (SAP) and set of TLF shells (\n",
      "\t 197 \t te statistical analysis plan (SAP) and set of TLF shells (as pr\n",
      "\t 197 \t analysis, based on a separate SAP and set of TLF shells was com\n",
      "\t 198 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 19\n",
      "\t 198 \t l analysis identified in this SAP and relevant set of TLF shell\n",
      "\t 198 \t n of the final version of the SAP and relevant set of TLF shell\n",
      "\t 199 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 20\n",
      "\t 200 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 21\n",
      "\t 201 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 22\n",
      "\t 202 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 23\n",
      "\t 203 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 24\n",
      "\t 204 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 25\n",
      "\t 205 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 26\n",
      "\t 205 \t s provided together with this SAP describe the presentations fo\n",
      "\t 206 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 27\n",
      "\t 207 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 28\n",
      "\t 208 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 29\n",
      "\t 209 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 30\n",
      "\t 210 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 31\n",
      "\t 211 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 32\n",
      "\t 212 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 33\n",
      "\t 213 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 34\n",
      "\t 214 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 35\n",
      "\t 215 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 36\n",
      "\t 216 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 37\n",
      "\t 217 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 38\n",
      "\t 218 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 39\n",
      "\t 219 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 40\n",
      "\t 220 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 41\n",
      "\t 221 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 42\n",
      "\t 222 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 43\n",
      "\t 223 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 44\n",
      "\t 224 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 45\n",
      "\t 225 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 46\n",
      "\t 226 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 47\n",
      "\t 227 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 48\n",
      "\t 228 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 49\n",
      "\t 229 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 50\n",
      "\t 230 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 51\n",
      "\t 231 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 52\n",
      "\t 232 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 53\n",
      "\t 233 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 54\n",
      "\t 234 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 55\n",
      "\t 235 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 56\n",
      "\t 236 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 57\n",
      "\t 237 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 58\n",
      "\t 238 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 59\n",
      "\t 239 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 60\n",
      "\t 240 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 61\n",
      "\t 241 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 62\n",
      "\t 242 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 63\n",
      "\t 243 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 64\n",
      "\t 244 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 65\n",
      "\t 245 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 66\n",
      "\t 246 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 67\n",
      "\t 247 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 68\n",
      "\t 248 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 69\n",
      "\t 249 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 70\n",
      "\t 250 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 71\n",
      "\t 251 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 72\n",
      "\t 252 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 73\n",
      "\t 253 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 74\n",
      "\t 254 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 75\n",
      "\t 255 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 76\n",
      "\t 256 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 77\n",
      "\t 257 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 78\n",
      "\t 258 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 79\n",
      "\t 259 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 80\n",
      "\t 260 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 81\n",
      "\t 261 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 82\n",
      "\t 262 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 83\n",
      "\t 263 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 84\n",
      "\t 264 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 85\n",
      "\t 265 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 86\n",
      "\t 266 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 87\n",
      "\t 267 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 88\n",
      "\t 268 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 89\n",
      "\t 269 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 90\n",
      "\t 270 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 1 \n",
      "\t 270 \t COL C‐040‐404   Page 1 of 91  STATISTICAL ANALYSIS PLAN   FINAL ANALYSIS        C‐040\n",
      "\t 271 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 2 \n",
      "\t 271 \t COL C‐040‐404   Page 2 of 91  STATISTICAL ANALYSIS PLAN SIGNATURE PAGE   Statistical \n",
      "\t 271 \t NALYSIS PLAN SIGNATURE PAGE   Statistical Analysis Plan Version 2.0 (Dated 29SEP2017)\n",
      "\t 271 \t d approve this version of the Statistical Analysis Plan, authorizing  that the conten\n",
      "\t 272 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 3 \n",
      "\t 273 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 4 \n",
      "\t 274 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 5 \n",
      "\t 275 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 6 \n",
      "\t 276 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 7 \n",
      "\t 277 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 8 \n",
      "\t 278 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 9 \n",
      "\t 279 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 10\n",
      "\t 279 \t erformed on the data.    This SAP is based on protocol Final Ve\n",
      "\t 280 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 11\n",
      "\t 281 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 12\n",
      "\t 282 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 13\n",
      "\t 283 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 14\n",
      "\t 284 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 15\n",
      "\t 285 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 16\n",
      "\t 286 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 17\n",
      "\t 286 \t  be performed as part of this SAP, as agreed by Aeras:  o Ident\n",
      "\t 286 \t prepare a separate correlates SAP once the trial’s efficacy res\n",
      "\t 287 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 18\n",
      "\t 287 \t  reviews, based on a separate statistical analysis plan (SAP) and set of TLF shells (\n",
      "\t 287 \t te statistical analysis plan (SAP) and set of TLF shells (as pr\n",
      "\t 287 \t analysis, based on a separate SAP and set of TLF shells was com\n",
      "\t 288 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 19\n",
      "\t 288 \t l analysis identified in this SAP and relevant set of TLF shell\n",
      "\t 288 \t n of the final version of the SAP and relevant set of TLF shell\n",
      "\t 289 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 20\n",
      "\t 290 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 21\n",
      "\t 291 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 22\n",
      "\t 292 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 23\n",
      "\t 293 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 24\n",
      "\t 294 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 25\n",
      "\t 295 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 26\n",
      "\t 295 \t s provided together with this SAP describe the presentations fo\n",
      "\t 296 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 27\n",
      "\t 297 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 28\n",
      "\t 298 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 29\n",
      "\t 299 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 30\n",
      "\t 300 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 31\n",
      "\t 301 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 32\n",
      "\t 302 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 33\n",
      "\t 303 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 34\n",
      "\t 304 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 35\n",
      "\t 305 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 36\n",
      "\t 306 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 37\n",
      "\t 307 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 38\n",
      "\t 308 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 39\n",
      "\t 309 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 40\n",
      "\t 310 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 41\n",
      "\t 311 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 42\n",
      "\t 312 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 43\n",
      "\t 313 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 44\n",
      "\t 314 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 45\n",
      "\t 315 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 46\n",
      "\t 316 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 47\n",
      "\t 317 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 48\n",
      "\t 318 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 49\n",
      "\t 319 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 50\n",
      "\t 320 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 51\n",
      "\t 321 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 52\n",
      "\t 322 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 53\n",
      "\t 323 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 54\n",
      "\t 324 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 55\n",
      "\t 325 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 56\n",
      "\t 326 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 57\n",
      "\t 327 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 58\n",
      "\t 328 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 59\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 329 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 60\n",
      "\t 330 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 61\n",
      "\t 331 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 62\n",
      "\t 332 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 63\n",
      "\t 333 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 64\n",
      "\t 334 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 65\n",
      "\t 335 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 66\n",
      "\t 336 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 67\n",
      "\t 337 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 68\n",
      "\t 338 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 69\n",
      "\t 339 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 70\n",
      "\t 340 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 71\n",
      "\t 341 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 72\n",
      "\t 342 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 73\n",
      "\t 343 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 74\n",
      "\t 344 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 75\n",
      "\t 345 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 76\n",
      "\t 346 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 77\n",
      "\t 347 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 78\n",
      "\t 348 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 79\n",
      "\t 349 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 80\n",
      "\t 350 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 81\n",
      "\t 351 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 82\n",
      "\t 352 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 83\n",
      "\t 353 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 84\n",
      "\t 354 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 85\n",
      "\t 355 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 86\n",
      "\t 356 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 87\n",
      "\t 357 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 88\n",
      "\t 358 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 89\n",
      "\t 359 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 90\n",
      "\t 360 \t n is strictly prohibited.     STATISTICAL ANALYSIS PLAN: PROTOCOL C‐040‐404   Page 91\n",
      "\t 361 \t     STATISTICAL ANALYSIS PLAN CHANGES: PROTOCOL C-040-404  \n",
      "\t 361 \t here were two versions of the statistical analysis plan for the C-040-404 protocol. T\n",
      "\t 361 \t esented in Version 2.0 of the statistical analysis plan) is presented below.   MODIFI\n",
      "\t 361 \t resholds was incorrect in the SAP. Instead, the analysis should\n",
      "\t 361 \t nsitivity analysis (p. 39  of SAP v2.0), have been corrected as\n",
      "\t 362 \t     STATISTICAL ANALYSIS PLAN CHANGES: PROTOCOL C-040-404  \n",
      "\t 363 \t s and SAPs \tCombined protocol-SAP document - wo TOC \tC-040-404_\n",
      "HIV-HIV-2016-HVTN114.pdf 126\n",
      "\t 34 \t pecific vaccination time, the Statistical Analysis Plan  (SAP) will address how to an\n",
      "\t 34 \t e Statistical Analysis Plan  (SAP) will address how to analyze \n",
      "\t 36 \t tails will be provided in the SAP.    \n",
      "\t 37 \t tails will be provided in the SAP.  An appropriate data transfo\n",
      "HIV-HIV-2018-Long-acting Cabotegravir Plus Long-acting Rilpivirine.pdf 242\n",
      "NUT-S-2018-R-S.pdf 113\n",
      "VAC-Tdap-2019-Sancovski-A Post-marketing, Observational, Retrospective.pdf 82\n",
      "NTD-t-2017-M-E.pdf 118\n",
      "\t 11 \t   SAE Serious Adverse Event   SAP Statistical Analysis Plan   S\n",
      "\t 11 \t E Serious Adverse Event   SAP Statistical Analysis Plan   SNC Central Nervous System \n",
      "\t 16 \t  planned in the protocol  and SAP will be performed.      Prima\n",
      "\t 63 \t Methods   A draft of the full Statistical Analysis Plan (SAP) will be prepared prior \n",
      "\t 63 \t ll Statistical Analysis Plan (SAP) will be prepared prior to   \n",
      "\t 63 \t he statistical   methods. The SAP will be reviewed and, if nece\n",
      "\t 69 \t lyses may be described in the SAP.                             \n",
      "\t 72 \t ribed in detail in a separate SAP, which will be finalised prio\n",
      "\t 72 \t ribed in detail in a separate SAP, which will be finalised prio\n",
      "MAL-M-2018-D-C.pdf 74\n",
      "NTD-D-2017-S-P.pdf 85\n",
      "\t 68 \t ical and Analytical Plans   A statistical analysis plan (SAP) will be prepared and fi\n",
      "\t 68 \t  A statistical analysis plan (SAP) will be prepared and finaliz\n",
      "HIV-HIV-2016-Garrett-HVTN108.pdf 155\n",
      "\t 50 \t l be defined in the  HVTN 108 Statistical Analysis Plan (SAP).   \n",
      "\t 50 \t 08 Statistical Analysis Plan (SAP).   \n",
      "\t 54 \t ecific vaccination time, the  Statistical Analysis Plan (SAP) will address how to ana\n",
      "\t 54 \t e  Statistical Analysis Plan (SAP) will address how to analyze \n",
      "\t 54 \t city assays  specified in the SAP, when the assay is viewed as \n",
      "\t 56 \t say will be described in the  SAP.   All of the primary assays,\n",
      "HIV-HIV-2018-Labhardt-CASCADE.pdf 90\n",
      "TB-TB-2019-Dawson-A Phase 2 Open‐Label Partially .pdf 112\n",
      "\t 12 \t  SAE  Serious Adverse Event   SAP  Statistical Analysis Plan   \n",
      "\t 12 \t  Serious Adverse Event   SAP  Statistical Analysis Plan   SBP  Systolic Blood Pressur\n",
      "\t 17 \t as exploratory  analyses. The Statistical Analysis Plan (SAP) will be developed befor\n",
      "\t 17 \t he Statistical Analysis Plan (SAP) will be developed before the\n",
      "\t 88 \t 8. STATISTICAL ANALYSIS   The statistical analysis plan (SAP), which will contain det\n",
      "\t 88 \t he statistical analysis plan (SAP), which will contain details \n",
      "\t 88 \t ations will be defined in the SAP.   In particular, the Safety \n",
      "MAL-MAL-2018-Dorsey-PROMOTE Birth Cohort 1.pdf 94\n",
      "PNE-P-2019-C-P.pdf 91\n",
      "\t 8 \t   SAE serious adverse event   SAP Statistical Analysis Plan   S\n",
      "\t 8 \t E serious adverse event   SAP Statistical Analysis Plan   SC Subcutaneous   SCC Scien\n",
      "\t 70 \t e outlined below. A detailed  Statistical Analysis Plan (SAP) for preparation of the \n",
      "\t 70 \t d  Statistical Analysis Plan (SAP) for preparation of the final\n",
      "\t 71 \t f warranted as defined in the SAP.    The Per Protocol Immunoge\n",
      "\t 72 \t yses will be described in the SAP.    No formal interim analyse\n",
      "\t 72 \t es  will be documented in the SAP.   12.3. Statistical Methods \n",
      "HIV-HIV-2019-Venter-ADVANCE.pdf 184\n",
      "\t 1 \t changes to the protocol,  and statistical analysis plan (the original version was unc\n",
      "\t 7 \t   SAE serious adverse event   SAP statistical analysis plan   T\n",
      "\t 7 \t E serious adverse event   SAP statistical analysis plan   TAF tenofovir alafenamide  \n",
      "\t 35 \t efined in more detail in the  statistical analysis plan (SAP). Patients will be analy\n",
      "\t 35 \t e  statistical analysis plan (SAP). Patients will be analysed a\n",
      "\t 52 \t   SAE serious adverse event   SAP statistical analysis plan   T\n",
      "\t 52 \t E serious adverse event   SAP statistical analysis plan   TAF   TB   TDF   tenofovir \n",
      "\t 89 \t efined in more detail in the  statistical analysis plan (SAP). Patients will be analy\n",
      "\t 89 \t e  statistical analysis plan (SAP). Patients will be analysed a\n",
      "\t 89 \t tails will be provided in the statistical analysis plan.      9.7 Primary Efficacy An\n",
      "\t 90 \t y outcomes.      See WRHI 060 Statistical Analysis Plan (SAP) for more details.   10.\n",
      "\t 90 \t 60 Statistical Analysis Plan (SAP) for more details.   10.0 Dat\n",
      "HIV-HIV-2019-K-C.pdf 191\n",
      "PNE-Pneumonia-2019-Alexander-LEAP2.pdf 175\n",
      "\t 28 \t cid SAE Serious Adverse Event SAP Statistical Analysis Plan SEN\n",
      "\t 28 \t SAE Serious Adverse Event SAP Statistical Analysis Plan SENTRY SENTRY Antimicrobial S\n",
      "\t 66 \t l be  presented in a separate SAP and results will be presented\n",
      "\t 74 \t  data will be outlined in the SAP.  As a consequence of differi\n",
      "\t 74 \t l be presented in a  separate SAP and results will be presented\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 79 \t l be presented in a  separate SAP and results will be presented\n",
      "\t 80 \t  and will be  detailed in the SAP. For both ECR and IACR, addit\n",
      "\t 81 \t d will be detailed in the EMA SAP.  9.6.2 Secondary Efficacy An\n",
      "\t 83 \t fied criteria outlined in the SAP.  Change from baseline to eac\n",
      "\t 83 \t times will be provided in the SAP. For analyses of the primary \n",
      "\t 83 \t mes will be presented in the  SAP.  9.9 Pharmacokinetic Analyse\n",
      "\t 84 \t ll be described in a separate SAP.  Results of  this analysis w\n",
      "\t 84 \t l be presented in a  separate SAP and results will be presented\n",
      "\t 102 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 102 \t -BC-3781-3102         FINAL   STATISTICAL ANALYSIS PLAN                              \n",
      "\t 103 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 104 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 105 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 106 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 106 \t n  SAE Serious Adverse Event  SAP Statistical Analysis Plan  SD\n",
      "\t 106 \t AE Serious Adverse Event  SAP Statistical Analysis Plan  SD Standard deviation  SEC S\n",
      "\t 107 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 107 \t  64   1.0 INTRODUCTION   This statistical analysis plan (SAP) provides the framework \n",
      "\t 107 \t is statistical analysis plan (SAP) provides the framework for t\n",
      "\t 107 \t onia”.  Changes made to  this SAP after it has been signed but \n",
      "\t 107 \t  will not be included in this SAP.  A  separate analysis plan w\n",
      "\t 107 \t n pneumonia symptoms.    This SAP addresses the primary efficac\n",
      "\t 107 \t e and analyses for the FDA. A SAP Addendum  will be developed t\n",
      "\t 108 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 109 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 110 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 111 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 112 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 113 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 114 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 114 \t  defined as pathogens in this SAP will be evaluated on a case b\n",
      "\t 115 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 116 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 117 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 118 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 119 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 120 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 121 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 122 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 123 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 124 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 125 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 126 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 126 \t cy outcomes specified in this SAP include:    Percentabe of sub\n",
      "\t 127 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 128 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 129 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 130 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 130 \t ll be presented in a separate SAP and  results will be presente\n",
      "\t 131 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 132 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 133 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 133 \t he database is locked and the SAP  is final, the study blind co\n",
      "\t 134 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 135 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 136 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 137 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 138 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 139 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 140 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 141 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 142 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 143 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 144 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 145 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 146 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 147 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 148 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 149 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 150 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 151 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 152 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 153 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 154 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 154 \t cy analyses specified in this SAP include summaries of the foll\n",
      "\t 155 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 156 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 157 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 158 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 159 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 160 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3102  \n",
      "\t 161 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3101  \n",
      "\t 162 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3101  \n",
      "\t 163 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3101  \n",
      "\t 164 \t  Nabriva Therapeutics AG  Statistical Analysis Plan – Protocol NAB-BC-3781-3101  \n",
      "\t 165 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 165 \t -BC-3781-3102         FINAL   STATISTICAL ANALYSIS PLAN ADDENDUM   EUROPEAN MEDICINES\n",
      "\t 166 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 167 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 167 \t monia Outcomes Research Team  SAP Statistical Analysis Plan  TO\n",
      "\t 167 \t a Outcomes Research Team  SAP Statistical Analysis Plan  TOC Test of Cure  US United \n",
      "\t 168 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 168 \t  11   1.0 INTRODUCTION   This statistical analysis plan (SAP) provides the framework \n",
      "\t 168 \t is statistical analysis plan (SAP) provides the framework for t\n",
      "\t 168 \t monia.”  Changes made to the  SAP after it has been signed but \n",
      "\t 168 \t sis  of this study, a Primary SAP and a SAP Addendum have been \n",
      "\t 168 \t is study, a Primary SAP and a SAP Addendum have been developed.\n",
      "\t 168 \t um have been developed.  This SAP Addendum  applies to regions \n",
      "\t 168 \t f the EMA, while the Primary  SAP details the approach for the \n",
      "\t 168 \t pproach for the US FDA.  This SAP Addendum addresses the differ\n",
      "\t 168 \t regions, refer to the Primary SAP.   2.0 STUDY DESIGN   Refer t\n",
      "\t 168 \t DESIGN   Refer to the Primary SAP.   3.0 STUDY OBJECTIVES   The\n",
      "\t 168 \t  same as those in the Primary SAP.   4.0 PATHOGEN IDENTIFICATIO\n",
      "\t 168 \t CATION   Refer to the Primary SAP.   \n",
      "\t 169 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 169 \t S SETS   Refer to the Primary SAP.   6.0 DEFINITIONS OF OUTCOME\n",
      "\t 169 \t efficacy outcomes in this EMA SAP Addendum differ  compared to \n",
      "\t 169 \t ffer  compared to the Primary SAP, the definitions and details \n",
      "\t 169 \t ully described in the Primary SAP.   7.0 STATISTICAL METHODS   \n",
      "\t 170 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 170 \t methods, refer to the Primary SAP.  8.0 STATISTICAL ANALYSES  T\n",
      "\t 170 \t SES  The changes for this EMA SAP Addendum in this section as c\n",
      "\t 170 \t  as compared with the Primary SAP  relate to the primary effica\n",
      "\t 171 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 172 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 173 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "\t 174 \t  Nabriva Therapeutics AG  Statistical Analysis Plan Addendum (EMA) – Protocol NAB\n",
      "MAT-Cervical Disease-2019-Greene-LEEP.pdf 296\n",
      "TB-TB-2018-Churchyard-Bedaquiline-Delamanid.pdf 119\n",
      "\t 82 \t  which will be given in   the Statistical Analysis Plan. For example, for each DLM, i\n",
      "\t 85 \t . Details are provided in the Statistical Analysis Plan.      10.4 Anticipated Outcom\n",
      "MAL-Malaria-2019-Foy-RIMDAMAL.pdf 58\n",
      "\t 47 \t to where other details of the statistical analysis plan can be found, if not in the p\n",
      "TB-TB-2019-N-S.pdf 224\n",
      "\t 1 \t mary of changes.  2. Original statistical analysis plan (1.0), final statistical anal\n",
      "\t 1 \t al analysis plan (1.0), final statistical analysis plan (1.1), a summary of  changes \n",
      "\t 50 \t rial results   approving the statistical analysis plan   approving the publication \n",
      "\t 129 \t ill be described fully in the statistical analysis plan.    Stage 1  In general, the \n",
      "\t 144 \t rial results   approving the statistical analysis plan   approving the publication \n",
      "\t 158 \t led trial             STAGE 1 STATISTICAL   ANALYSIS PLAN   v.1.0  | MARCH 2015        \n",
      "\t 159 \t t the  STREAM protocol.  This Statistical Analysis Plan (SAP) supersedes version 0.1 \n",
      "\t 159 \t is Statistical Analysis Plan (SAP) supersedes version 0.1 of th\n",
      "\t 159 \t supersedes version 0.1 of the SAP.   Every care was taken in th\n",
      "\t 159 \t taken in the drafting of this SAP, but corrections or amendment\n",
      "\t 159 \t ry.  The final version of the SAP will be signed off before dat\n",
      "\t 159 \t have SAPs listed below.  Each SAP has differences, but the fund\n",
      "\t 159 \t ocument Description   Stage 1 SAP All analyses relating to stag\n",
      "\t 159 \t ing to stage 1   Core Stage 2 SAP Core analyses for stage 2 rel\n",
      "\t 159 \t base lock   Extensive Stage 2 SAP Expanded analyses for stage 2\n",
      "\t 159 \t  lock   Core Stage 2 Week 132 SAP Core analyses for stage 2 rel\n",
      "\t 159 \t    Extensive Stage 2 Week 132 SAP Expanded analyses for stage 2\n",
      "\t 160 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 3   Sponsor: \n",
      "\t 162 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 5   10 Data s\n",
      "\t 164 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 7   PZA Pyraz\n",
      "\t 164 \t ehl-Neelsen     Note. In this statistical analysis plan, time (in weeks) refers to th\n",
      "\t 166 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 9   2. Is age\n",
      "\t 168 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 11    Study i\n",
      "\t 170 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 13   Figure 3\n",
      "\t 172 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 15   Table 2:\n",
      "\t 174 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 17   Changes \n",
      "\t 176 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 19   5 GENERA\n",
      "\t 178 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 21    Definit\n",
      "\t 180 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 23   B and Re\n",
      "\t 182 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 25    Efficac\n",
      "\t 184 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 27   7.3.1 Pl\n",
      "\t 186 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 29      8.2.2\n",
      "\t 188 \t  STREAM      STREAM Stage 1 SAP v1.0 March 2015 31   9 SENSIT\n",
      "\t 191 \t led trial             STAGE 1 STATISTICAL   ANALYSIS PLAN   v.1.1  | June 2017         \n",
      "\t 192 \t t the  STREAM protocol.  This Statistical Analysis Plan (SAP) supersedes version 0.1 \n",
      "\t 192 \t is Statistical Analysis Plan (SAP) supersedes version 0.1 of th\n",
      "\t 192 \t supersedes version 0.1 of the SAP.   Every care was taken in th\n",
      "\t 192 \t taken in the drafting of this SAP, but corrections or amendment\n",
      "\t 192 \t ry.  The final version of the SAP will be signed off before dat\n",
      "\t 192 \t have SAPs listed below.  Each SAP has differences, but the fund\n",
      "\t 192 \t ocument Description   Stage 1 SAP All analyses relating to stag\n",
      "\t 192 \t ing to stage 1   Core Stage 2 SAP Core analyses for stage 2 rel\n",
      "\t 192 \t base lock   Extensive Stage 2 SAP Expanded analyses for stage 2\n",
      "\t 192 \t  lock   Core Stage 2 Week 132 SAP Core analyses for stage 2 rel\n",
      "\t 192 \t    Extensive Stage 2 Week 132 SAP Expanded analyses for stage 2\n",
      "\t 193 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 3   Sponsor:  \n",
      "\t 194 \t ly unclear.  Now in line with SAP for  Stage 2.   3.2 Inclusion\n",
      "\t 195 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 5   whether or\n",
      "\t 197 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 7   10 Data sh\n",
      "\t 199 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 9   PZA Pyrazi\n",
      "\t 199 \t ehl-Neelsen     Note. In this statistical analysis plan, time (in weeks) refers to th\n",
      "\t 201 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 11    Study in\n",
      "\t 203 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 13   Figure 3:\n",
      "\t 205 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 15   Table 2: \n",
      "\t 207 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 17   6. A drug\n",
      "\t 209 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 19   5 GENERAL\n",
      "\t 211 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 21    Definiti\n",
      "\t 213 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 23    Primary \n",
      "\t 215 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 25   7.2.2 Tim\n",
      "\t 217 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 27   7.3.4 Pro\n",
      "\t 219 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 29     These t\n",
      "\t 221 \t  STREAM      STREAM Stage 1 SAP v1.1 June 2017 31   10 DATA S\n",
      "NUT-Stunting-2019-Humphrey-SHINE.pdf 91\n",
      "PNE-Pneumonia-2018-Keenan-Mortality Reduction After Oral Azithromycin.pdf 184\n",
      "\t 1 \t es.          2.      Original statistical analysis plan, final statistical analysis p\n",
      "\t 1 \t tistical analysis plan, final statistical analysis plan, summary of changes.   \n",
      "\t 12 \t rovided in an appendix to the Statistical Analysis  Plan.     Study Participants: At m\n",
      "\t 58 \t nitoring is discussed in the  Statistical Analysis Plan. The Data Safety and Monitori\n",
      "\t 65 \t s of  the trial protocol, the Statistical Analysis Plan, the DSMC Charter, and the  c\n",
      "\t 74 \t      Niger  Malawi  Tanzania  SAP   Abbreviated Verbal Autopsy \n",
      "\t 85 \t rovided in an appendix to the Statistical Analysis  Plan.     Study Participants: At m\n",
      "\t 132 \t nitoring is discussed in the  Statistical Analysis Plan. The Data Safety and Monitori\n",
      "\t 140 \t s of  the trial protocol, the Statistical Analysis Plan, the DSMC Charter, and the  c\n",
      "\t 149 \t x    Niger  Malawi  Tanzania  SAP  Abbreviated Verbal Autopsy Q\n",
      "\t 152 \t ion after Oral  Azithromycin  Statistical Analysis Plan  UCSF Francis I. Proctor Foun\n",
      "\t 153 \t  Introduction  This document (Statistical Analysis Plan, SAP) describes the planned a\n",
      "\t 153 \t t (Statistical Analysis Plan, SAP) describes the planned analys\n",
      "\t 153 \t  placebo. The content of this Statistical Analysis Plan meets the requirements  state\n",
      "\t 153 \t viewed in preparation of this Statistical Analysis Plan:  • Mortality Reduction after\n",
      "\t 153 \t ed analyses described in this SAP will be included in future ma\n",
      "\t 153 \t ecessarily identified in this Statistical Analysis Plan may be per-  formed to suppor\n",
      "\t 166 \t  Mid upper arm circumference  SAP Statistical Analysis Plan  TF\n",
      "\t 166 \t  upper arm circumference  SAP Statistical Analysis Plan  TF Trachomatous inflammation\n",
      "\t 167 \t on  after Oral Azithromycin   Statistical Analysis Plan   UCSF Francis I. Proctor Fou\n",
      "\t 168 \t  Introduction  This document (Statistical Analysis Plan, SAP) describes the planned a\n",
      "\t 168 \t t (Statistical Analysis Plan, SAP) describes the planned analys\n",
      "\t 168 \t placebo. The content  of this Statistical Analysis Plan meets the requirements stated\n",
      "\t 168 \t viewed in preparation of this Statistical Analysis Plan:    • Mortality Reduction aft\n",
      "\t 168 \t ed analyses described in this SAP will be included in future ma\n",
      "\t 168 \t ecessarily identified in this Statistical Analysis Plan may be performed to support  \n",
      "\t 168 \t alyses not delineated in this Statistical Analysis Plan will be  documented as such i\n",
      "\t 180 \t id upper arm circumference    SAP Statistical Analysis Plan    \n",
      "\t 180 \t pper arm circumference    SAP Statistical Analysis Plan    TF Trachomatous inflammati\n",
      "\t 183 \t eferences \tAppendix  \tInitial SAP \tFinal SAP \tIntroduction \t1  \n",
      "\t 183 \t Appendix  \tInitial SAP \tFinal SAP \tIntroduction \t1  Summary \t1.\n",
      "EDD-Cholera-2016-Qadri-Shanchol.pdf 124\n",
      "\t 1 \t nts)   3. Final protocol   4. Statistical analysis plan         \n",
      "\t 32 \t he study, in   developing the data analysis plan, and in reviewing the divisio\n",
      "TB-TB-2020-John-Stewart-iTIPS.pdf 85\n",
      "VAC-Ecoli-2019-Qadri-ETVAX.pdf 65\n",
      "\t 42 \t  2015      43      A detailed statistical analysis plan for preparation of the final \n",
      "HIV-HIV-2018-Havlir-SEARCH.pdf 101\n",
      "\t 75 \t e study protocol, the primary statistical analysis plan,  and the trial safety stoppi\n",
      "HIV-HIV-2016-Kurth-High-yield HIV testing, facilitated linkage to care.pdf 111\n",
      "HIV-HIV-2017-Corey-HVTN704-HPTN085.pdf 175\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\t 58 \t  specific infusion visit, the Statistical  Analysis Plan will address how to analyze t\n",
      "\t 60 \t reatment arms [124,125].  The Statistical Analysis Plan will describe the details of \n",
      "\t 62 \t    A correlates of protection statistical analysis plan will be finalized not using a\n",
      "\t 62 \t HIV-1 virus at that time. The statistical analysis plan will describe the methods use\n",
      "\t 63 \t thods will be provided in the statistical analysis plan.   4.13.7.4 mAb markers    Fo\n",
      "\t 65 \t tions will be provided in the statistical analysis plan.    Figure 4-9 shows power cu\n",
      "HIV-HIV-2016_Tebas-A5354.pdf 133\n",
      "HIV-HIV-2016-Weinberg-NICHP1091.pdf 93\n",
      "MAL-Malaria-2016-Valencia-Phase 1 and 2a Clinical.pdf 61\n",
      "NTD-Filariasis-2019-Weil-DOLF IDA Indonesia.pdf 108\n",
      "VAC-M-2015-L-W.pdf 193\n",
      "\t 1 \t mary of changes   2. Original statistical analysis plan. No changes were made to the \n",
      "\t 1 \t . No changes were made to the statistical analysis plan.   \n",
      "\t 54 \t      3. Set up an alternative statistical analysis plan addressing the following elem\n",
      "\t 65 \t RFs on PDA   Vellore  VEL 1/1 Statistical Analysis Plan   (randomization and allocati\n",
      "\t 118 \t      3. Set up an alternative statistical analysis plan addressing the following elem\n",
      "\t 129 \t RFs on PDA   Vellore  VEL 1/1 Statistical Analysis Plan  VEL 2/1 Data management plan\n",
      "\t 132 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 132 \t             Page 1 of 61      STATISTICAL ANALYSIS PLAN      SOP No. VEL 1/1 Version-\n",
      "\t 132 \t     : Serious Adverse Event   SAP      : Statistical Analysis P\n",
      "\t 132 \t us Adverse Event   SAP      : Statistical Analysis Plan   SOP      : Standard Operati\n",
      "\t 133 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 134 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 134 \t ocument is referred to as the Statistical Analysis Plan (SAP).   The contents of the \n",
      "\t 134 \t he Statistical Analysis Plan (SAP).   The contents of the SAP a\n",
      "\t 134 \t  (SAP).   The contents of the SAP are in accordance with the gu\n",
      "\t 134 \t 3.0 Policy and Scope:     The SAP is applicable to procedures f\n",
      "\t 134 \t ding to the protocol and this SAP and to ensure that other resp\n",
      "\t 134 \t heir duties according to this SAP.      5.0 Materials and Equip\n",
      "\t 135 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 136 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 137 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 138 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 139 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 140 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 141 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 142 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 143 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 144 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 145 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 146 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 147 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 148 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 149 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 150 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 151 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 152 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 153 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 154 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 155 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 156 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 157 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 158 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 159 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 160 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 161 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 162 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 163 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 164 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 165 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 166 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 167 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 168 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 169 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 170 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 171 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 172 \t L 1/1:   September 11, 2012   Statistical Analysis Plan                          Page\n",
      "\t 173 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 174 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 175 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 176 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 177 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 178 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 179 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 180 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 181 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 182 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 183 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 184 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 185 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 186 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 187 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 188 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 189 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 190 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 191 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n",
      "\t 192 \t     SOP VEL 1/1:   Sep 2012   Statistical Analysis Plan                          Page\n"
     ]
    }
   ],
   "source": [
    "for file, pages in file_to_text.items():\n",
    "    print (file, len(pages))\n",
    "    for page_no, page_text in enumerate(pages):\n",
    "        matches = sap_regex.finditer(page_text)\n",
    "               \n",
    "        for match in matches:\n",
    "            l = int(np.max((0, match.start() - 30)))\n",
    "            r = int(np.min((len(page_text), match.end() + 30)))\n",
    "            print (\"\\t\", page_no, \"\\t\",  page_text[l:r].replace(\"\\n\", \" \"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "9322eba9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "76"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(files)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dafcb96e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
